AI Article Synopsis
- The relationship between COVID-19 and the endocrine system has become a significant focus of research, highlighting how conditions like obesity and diabetes increase the severity of COVID-19.
- Key endocrine organs have been affected by the virus, leading to new endocrine disorders, although the long-term consequences remain unclear.
- Additionally, pandemic-related "stay home" measures disrupted care for existing endocrine conditions, making it challenging to diagnose and treat new cases, indicating a need for further investigation into these interactions.
Article Abstract
The multifaceted interaction between coronavirus disease 2019 (COVID-19) and the endocrine system has been a major area of scientific research over the past two years. While common endocrine/metabolic disorders such as obesity and diabetes have been recognized among significant risk factors for COVID-19 severity, several endocrine organs were identified to be targeted by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). New-onset endocrine disorders related to COVID-19 were reported while long-term effects, if any, are yet to be determined. Meanwhile, the "stay home" measures during the pandemic caused interruption in the care of patients with pre-existing endocrine disorders and may have impeded the diagnosis and treatment of new ones. This review aims to outline this complex interaction between COVID-19 and endocrine disorders by synthesizing the current scientific knowledge obtained from clinical and pathophysiological studies, and to emphasize considerations for future research.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1146/annurev-med-043021-033509 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!